Whittington J, Raftery E
Br J Clin Pharmacol. 1980; 10(5):439-42.
PMID: 7437255
PMC: 1430143.
DOI: 10.1111/j.1365-2125.1980.tb01785.x.
Whittington J, Raftery E
Br J Clin Pharmacol. 1980; 10(3):211-5.
PMID: 7002181
PMC: 1430056.
DOI: 10.1111/j.1365-2125.1980.tb01746.x.
Siess W, Lorenz R, Roth P, Weber P
Agents Actions. 1983; 13(1):29-34.
PMID: 6344593
DOI: 10.1007/BF01994278.
Alvares R, Goodwin J
Br Heart J. 1982; 48(3):204-12.
PMID: 6125160
PMC: 481230.
DOI: 10.1136/hrt.48.3.204.
Chung D
Can Anaesth Soc J. 1981; 28(2):105-13.
PMID: 6113884
DOI: 10.1007/BF03007252.
Beta-adrenergic blockade and cardiac arrhythmias.
SLOMAN G, Stannard M
Br Med J. 1967; 4(5578):508-12.
PMID: 6065983
PMC: 1749176.
DOI: 10.1136/bmj.4.5578.508.
The ventricular pre-excitation (Wolff-Parkinson-White) syndrome.
Hayton R, Lopez J
Can Med Assoc J. 1968; 98(20):950-4.
PMID: 5657173
PMC: 1924149.
Beta-adrenoceptive responses in the unanaesthetized ovine foetus.
Van Petten G, WILLES R
Br J Pharmacol. 1970; 38(3):572-82.
PMID: 5441411
PMC: 1702568.
DOI: 10.1111/j.1476-5381.1970.tb10598.x.
Influence of cirrhosis on production of atheroarteriosclerosis and thromboarteritis with vitamin D and dietary cholesterol.
HASS G, Henson D, Scott R, Mcclain E, HEMMENS A
Am J Pathol. 1969; 57(2):405-29.
PMID: 5360271
PMC: 2013620.
Experimental observations on propranolol in anaesthesia.
LEWIS G
Can Anaesth Soc J. 1969; 16(6):547-56.
PMID: 5346845
DOI: 10.1007/BF03004548.
Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.
Sandler G, Pistevos A
Br Med J. 1971; 1(5743):254-7.
PMID: 5100496
PMC: 1794979.
DOI: 10.1136/bmj.1.5743.254.
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
Farmer J, Kennedy I, Levy G, Marshall R
Br J Pharmacol. 1972; 45(4):660-75.
PMID: 4404413
PMC: 1665961.
DOI: 10.1111/j.1476-5381.1972.tb08125.x.
Effects of (plus or minus)-propranolol, (plus or minus)-,(plus)-, and (minus)-alprenolol on unanaesthetized dogs with ventricular arrhythmias resulting from coronary artery ligation.
Duce B, GARBERG L, Smith E
Br J Pharmacol. 1970; 39(4):809-16.
PMID: 4394971
PMC: 1702731.
DOI: 10.1111/j.1476-5381.1970.tb09907.x.
Clinical experience with dextro-alprenolol.
Vohra J, Thompson P, SLOMAN J
Br Med J. 1970; 1(5699):791-2.
PMID: 4392655
PMC: 1699672.
DOI: 10.1136/bmj.1.5699.791.
Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
Aubert A, Nyberg G, Slaastad R, Tjeldflaat L
Br Med J. 1970; 1(5690):203-6.
PMID: 4391702
PMC: 1699297.
DOI: 10.1136/bmj.1.5690.203.
[Adrenergic alpha and beta receptors and their specific inhibitors].
Muscholl E, Rahn K
Klin Wochenschr. 1968; 46(3):113-9.
PMID: 4385910
DOI: 10.1007/BF01727368.
Effects of oxyfedrine and ouabain on the heart-lung preparation of the dog.
Sakai K, Sugano S, ISONO C
Naunyn Schmiedebergs Arch Pharmacol. 1973; 277(1):89-102.
PMID: 4267600
DOI: 10.1007/BF00498787.
Beta-adrenergic blocking agents and anaesthesia: a review.
WARNER W
Can Anaesth Soc J. 1968; 15(1):42-55.
PMID: 4157255
DOI: 10.1007/BF03005868.
Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
AStrom H, Vallin H
Br Heart J. 1974; 36(12):1194-1200.
PMID: 4155316
PMC: 458942.
DOI: 10.1136/hrt.36.12.1194.
Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.
Picca M, Azzollini F, Cereda A, Pelosi G
Eur J Clin Pharmacol. 1989; 37(4):325-31.
PMID: 2513206
DOI: 10.1007/BF00558494.
